@medixocentre
Imatinib is a derivative of 2-phenylaminopyrimidine (CH2SO3H). Studies in cell cultures of CML patients have shown that Gleevec suppresses the growth of Ph-positive cells, with almost no effect on Ph-negative cells. The mechanism of the action of Gleevec that blocks the activity of ABL-tyrosine kinase is associated with the incorporation of the drug molecule into the place in the ABL-tyrosine kinase molecule - the ATP pocket, where ATP is usually embedded.
Read more-https://www.medixocentre.com/g....leevec-imatinib-pric
The main important thing is about costing of this magic medicine which out of pocket for middle class family. Many patients could not afford Epclusa cost so they had to choose conservative treatment with other drugs. Not only were they ineffective, but they might also delay the condition. Here is good news for everyone: the generic version of Epclusa entered into the Indian market.
You can read more on Epclusa cost here-
https://www.medixocentre.com/epclusa-cost